Petros Pharmaceuticals, Inc.
PTPI
$0.0275
-$0.0005-1.79%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.93% | -61.24% | -75.41% | 62.79% | 67.90% |
| Total Depreciation and Amortization | -15.43% | -43.85% | -57.96% | -55.54% | -60.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 74.65% | 358.94% | 307.30% | -403.97% | -145.97% |
| Change in Net Operating Assets | 4,220.22% | 162.66% | 382.91% | 488.91% | -101.60% |
| Cash from Operations | 50.86% | 60.96% | 65.87% | 15.98% | -96.09% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 48.10% | 65.14% | 73.66% | 40.40% | 41.42% |
| Issuance of Common Stock | -41.95% | -41.95% | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | 20.01% | -63.85% | -211.88% | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -52.51% | -73.74% | -160.67% | -159.95% | 823.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -284.18% | -111.73% | -346.17% | -307.35% | 101.27% |